Walker walks the walk at IDEA Pharma

IDEA Pharma is delighted to announce the appointment of Dr. Graham Walker to its IDEAtion team. Join..

Which Pharma company is leading the charge in Productive Innovation for 2012?

IDEA Pharma has launched the second annual Productive Innovation Index (PII), ranking 21 global phar..

Prepared to Launch - EBR article

For a closer look, go to: http://www.samedanltd.com/magazine/current/12 Lifecycle decisions are ..

Get down with the lingo

For something that is supposed to be so clear, the terms used in Pharma strategy can cause confu..

Sales in the City

With IDEA Pharma’s US operations securing an ever-stronger foothold, awareness is growing as t..

IDEA Pharma expands its European headquarters

As IDEA Pharma widens its net across Europe, business is booming as the ‘IDEA house’..

Like attracts like at IDEA Pharma

As the ‘IDEA revolution’ continues to make waves within Pharma, more and more compan..

Mike Rea makes the top 100 Most Inspiring People in the Life-Sciences Industry list

IDEA Pharma’s Principal IDEAtor, Mike Rea, has been voted among the PharmaVOICE Top 100 Mo..

The 5 Enemies of Innovation

The industry has a well-recognised problem. There is a prevailing view that developing drugs is ..

Not all drug development is the same: How pharmaceutical companies rank in productive innovation

IDEA Pharma makes public its annual Productive Innovation Index (PII) With only one in four ..

IDEAtion

IDEAtion is the process of building IDEAs. IDEAtion ensures the potential or the talent of a mol..

Brand Names

This is not an industry that does what is easy instead of what is best. This is not an industry ..

Communications

It used to be that those involved in the process of communication understood which part of the p..

Efficacy

Here’s the thing about Efficacy. It doesn’t exist. It is an abstract concept, a shorthan..

Scenario Planning

Cards on the table: no two ‘scenario planning’ projects are the same, or should be t..

Not all drug development is the same: How pharmaceutical companies rank in productive innovation

IDEA Pharma makes public its annual Productive Innovation Index (PII)

With only one in four molecules ever making a return on investment once launched, IDEA Pharma, strategy specialist at Phase II, makes public its annual Productive Innovation Index (PII), to highlight and rank the Top 13 global pharmaceutical companies for commercial added value across their portfolios.

PII starts with a very basic proposition: If two drug companies were given the same molecule to develop and market, which one would be more successful at seeing a return on investment? “Innovation is only innovation if you launch it. Having a great pipeline, or a great product, is only one predictor of success. It is a good starting point, but how well the molecule is developed and marketed is critical in its probability of commercial success – that is reflected in our relative rankings,” comments Mike Rea, IDEA Pharma’s CEO.

“A company that talks the language of innovation is saying that it is better at finding unmet need that others haven't spotted, or delivering / developing products that others can't, not just that it is discovering better raw products. However, the emphasis on 'clever' biology, mechanisms, science, diagnostics, etc., has not been matched (in most places) with an enhanced discipline of putting innovation onto the market.” he concludes.

PII uses objective measures of strategic performance over the 2005-2010 time period, to rank Top 13 companies.

Ranking:

1.    Johnson & Johnson

2.    Amgen

3.    Eli Lilly

4.    F. Hoffmann-La Roche/ Genentech

5.    Sanofi-Aventis          

6.    Novartis

7.    Pfizer

8.    Abbott

9.    Merck & Co

10. GSK

11. Bayer

12. AstraZeneca

13. Bristol Myers Squibb
We appreciate your feedback!
Write a comment